Skip to content
Recall Observatory FDA recall evidence

Drug product

Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01

D-0486-2026

March 20, 2026

Class II

Product summary

Firm
Leading Pharma, LLC
Event
Event 98628
Status
Ongoing
Classification
Class II
Quantity
9384 bottles
Official record key
drug-enforcement:D-0486-2026

Official wording

Reason: CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.

Code information: Lots# H03125, H03225, H03325, Exp Date: 2027/08

Distribution pattern: US Nationwide.

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations